Back to News
Market Impact: 0.2
Bragar Eagel & Squire, P.C. Urges Capricor Therapeutics, Inc. Investors With Large Losses to Contact the Firm Before the September 28th Deadline
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bragar Eagel & Squire litigation partner Brandon Walker is soliciting Capricor Therapeutics (CAPR) investors who suffered losses to discuss potential legal options. The notice indicates potential investor litigation risk for the biotech company, though it provides no allegations, financial damages, case milestones, or operating updates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.75
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- EU charges TikTok over harmful algorithmic 'rabbit hole' effects
- Globus Medical stock holds at Neutral as BTIG cites revenue miss
- Man Group shares drop 5% after court ruling on legacy case
- Canaccord reiterates Natera stock rating on strong Q3 results
- Pulse Biosciences reports interim thyroid nodule study results